Health Condition 1: H200- Acute and subacute iridocyclitis
Conditions
Interventions
Intervention1: NIL: Not Applicable
Control Intervention1: NIL: Not Applicable
Sponsors
Aravind Eye Hospital Pondicherry
Eligibility
Inclusion criteria
Inclusion criteria: Patients attending the uvea clinic who are newly diagnosed with acute uveitis who are willing to undergo the test at the reference laboratory attached to Aravind Eye hospital, Pondicherry Chronic uveitis patients presenting with reactivation of the disease Patients of age 18 years and above
Exclusion criteria
Exclusion criteria: Patients with history of trauma Chronic uveitis patients with inactive disease Patients in the pediatric age groups Immunosuppressed patients Patients who are already on ACE inhibitors oral steroids or immunosuppressants
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Percentage of raised S.ACE levels (52IU/L) among patients with active uveitis Estimated values of Sensitivity, Specificity, Positive Predictive Value and Negative Predictive Value of serum ACE investigation in different etiologies of uveitis including ocular TB and Ocular Sarcoidosis by employing different cut-off values Timepoint: At 1 year | — |
Secondary
| Measure | Time frame |
|---|---|
| Percentage of positive Mantoux test value of more than 10mm and estimated values of Sensitivity, Specificity, Positive Predictive value and Negative Predictive Value of Mantoux test in Ocular TB and Ocular Sarcoidosis Percentage of occurrence of lymphopenia and estimated values of Sensitivity, Specificity, Positive Predictive value and Negative Predictive value of lymphopenia in Ocular TB and Ocular Sarcoidosis Timepoint: At Baseline (Day 0) | — |
Countries
India
Contacts
Public ContactDr S Balamurugan
Aravind Eye Hospital Pondicherry
Outcome results
None listed